CANTON, Mass. (AP) _ Organogenesis Holdings Inc. (ORGO) on Monday reported a loss of $4.4 million in its fourth quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had a loss of 4 cents.
The regenerative medicine company posted revenue of $74.6 million in the period.
For the year, the company reported a loss of $41.1 million, or 44 cents per share. Revenue was reported as $261 million.
Organogenesis expects full-year revenue in the range of $273 million to $277 million.